Back to launches
Launch2026-09-230 comments
StandardX Isotope Refinery🇬🇧
StandardX
StandardX unveiled its accelerator-based isotope-refinery program and raised £10 million to engineer its first industrial system in London, with initial medical-isotope delivery targeted for 2027. A flexible production platform could ease shortages of isotopes used in cancer diagnosis and treatment, research and fusion without relying entirely on aging, single-purpose infrastructure.
About the company
StandardX is engineering a compact, high-power particle-accelerator platform intended to produce multiple isotopes from a standardized installation. Founded in 2025, it is initially focused on supply for cancer diagnostics and treatment, research and future fusion systems.